Variant report
Variant | esv3438146 |
---|---|
Chromosome Location | chr7:146378069-146379367 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569421750 | chr7:146378238-146378239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs10260447 | chr7:146378314-146378315 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs148444337 | chr7:146378343-146378344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs10230303 | chr7:146378410-146378411 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs187305330 | chr7:146378411-146378412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142872098 | chr7:146378502-146378503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114753318 | chr7:146378520-146378521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74758671 | chr7:146378522-146378523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs111782740 | chr7:146378531-146378532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs811895 | chr7:146378543-146378544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs58404206 | chr7:146378742-146378743 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs200404832 | chr7:146378751-146378752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146049219 | chr7:146378752-146378753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77698510 | chr7:146378754-146378755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558736884 | chr7:146378791-146378792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575411608 | chr7:146378823-146378824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544527665 | chr7:146378835-146378836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577420153 | chr7:146378861-146378862 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146106138 | chr7:146378888-146378889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs55834213 | chr7:146378892-146378893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs2533121 | chr7:146378916-146378917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs530147019 | chr7:146378936-146378937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373946829 | chr7:146378996-146378997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560530662 | chr7:146379009-146379010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532642175 | chr7:146379049-146379050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140072349 | chr7:146379076-146379077 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563132603 | chr7:146379077-146379078 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143625636 | chr7:146379082-146379083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs112858415 | chr7:146379093-146379094 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs66939445 | chr7:146379102-146379103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201274427 | chr7:146379103-146379104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563815751 | chr7:146379104-146379105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs398067376 | chr7:146379105-146379106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111800247 | chr7:146379107-146379108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs112765755 | chr7:146379108-146379109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs530920564 | chr7:146379126-146379127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs566915320 | chr7:146379129-146379130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544278175 | chr7:146379168-146379169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148748291 | chr7:146379208-146379209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529604141 | chr7:146379223-146379224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs200347688 | chr7:146379266-146379267 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs61231420 | chr7:146379272-146379273 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs146780629 | chr7:146379277-146379278 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538740918 | chr7:146379279-146379280 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73455275 | chr7:146379291-146379292 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs373634372 | chr7:146379303-146379304 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569060243 | chr7:146379319-146379320 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538132959 | chr7:146379339-146379340 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2533120 | chr7:146379349-146379350 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146378200-146378400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr7:146378400-146379400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr7:146379000-146379400 | Enhancers | Stomach Mucosa | stomach |
4 | chr7:146379200-146380000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |